All bills
H.R. 10483·119th Congress·House Bill

Bone Marrow Radiation Shielding Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (17 Sep 2026): Referred to the House Committee on Armed Services.

What this bill does

This bill, titled the Bone Marrow Radiation Shielding Act, would direct a specific Pentagon official—the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs—to seek an agreement with a research center affiliated with U.S. Strategic Command. This agreement would be to conduct an independent scientific assessment. The assessment would specifically evaluate whether protecting bone marrow with partial body radiation shielding could enhance survival chances for individuals exposed to gamma radiation compared to those without such shielding.

The assessment's findings would be based on existing peer-reviewed scientific literature, laboratory studies, and relevant experimental data. It would examine the effectiveness of bone marrow shielding in relation to the likelihood and severity of Acute Radiation Syndrome, as well as overall mortality rates after gamma radiation exposure. This bill affects individuals who might be exposed to gamma radiation in certain scenarios, and its findings could inform future policy or protective measures.

As of now, H.R. 10483 has been introduced in the House of Representatives and referred to the Committee on Armed Services. If it advances, it would then need to be considered by the Senate. Should both chambers pass the bill, it would be sent to the President for signature or veto.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 17 Sep 2026

    Referred to the House Committee on Armed Services.

Common questions

What does H.R. 10483 do?
This bill, titled the Bone Marrow Radiation Shielding Act, would direct a specific Pentagon official—the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs—to seek an agreement with a research center affiliated with U.S. Strategic Command. This agreement would be to conduct an independent scientific assessment. The assessment would specifically evaluate whether protecting bone marrow with partial body radiation shielding could enhance survival chances for individuals exposed to gamma radiation compared to those without such shielding. The assessment's findings would be based on existing peer-reviewed scientific literature, laboratory studies, and relevant experimental data. It would examine the effectiveness of bone marrow shielding in relation to the likelihood and severity of Acute Radiation Syndrome, as well as overall mortality rates after gamma radiation exposure. This bill affects individuals who might be exposed to gamma radiation in certain scenarios, and its findings could inform future policy or protective measures. As of now, H.R. 10483 has been introduced in the House of Representatives and referred to the Committee on Armed Services. If it advances, it would then need to be considered by the Senate. Should both chambers pass the bill, it would be sent to the President for signature or veto.
Has H.R. 10483 become law?
The source does not supply a confirmed lifecycle stage for H.R. 10483. Check the latest action and official source below.
Who sponsored H.R. 10483?
H.R. 10483 was sponsored by Rep. Bacon, Don [R-NE-2] (R-NE), with 0 cosponsors.
What's the latest action on H.R. 10483?
Referred to the House Committee on Armed Services. (17 Sep 2026).

Related bills in Armed Forces and National Security

More bills from Rep. Bacon, Don [R-NE-2]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.